TORONTO and CAMBRIDGE, Mass., Aug. 17, 2017. BlueRock Therapeutics, which is developing cell-based therapies designed to alter the course of degenerative disease, today announces the expansion of the company's presence in Toronto with a research, development and manufacturing site in the MaRS Discovery District.
Canadian Mission to MassMEDIC's MedTech Showcase
Sernova Retains FronTier Merchant Capital for North America Investor Relations and Marketing
Iris Technologies: New Study Supports Non-LCD E-Paper Technology
US FDA launches Digital Health Innovation Action Plan & Pre-Certification Software Pilot Program
BIO Investor Forum Now Accepting Applications to Present
Ontario Health Trade Mission to Japan and Korea
Steadiwear Wins Most Innovative Start-up & Most Favorable Startup at Jumpstarter 2017 Wearables|IOT|EduTech Pitch Competition
Jumpstarter is a first-of-its-kind startup event that unites and empowers Hong Kong’s hottest startup sectors.
OBIO member company Steadiwear Inc. took home the titles of "Most Innovative Start-up” in the Wearables/IOT/EduTech Pitch Competition, and the “Most Favorable Startup”, as decided by audience votes, which earned them a spot in the Grand Finale.
CAAP Company: Intronix Technologies To Launch "Myoguide DOC", A Comprehensive Software Package Designed for Clinicians Utlilizing Botulinum Toxins to Manage Patient's Spasticity And Pain.
Mirexus Biotechnologies Inc. Raises $12 Million to Finance Factory, Fund Business Development, and Deepen R&D
Mirexus Biotechnologies Inc. (Mirexus) is excited to announce that it has closed an investment round of $12 million. Mirexus is a safe and natural nanomaterials company based in Guelph, Ontario that is commercializing PhytoSpherixTM, a novel technology based on polysaccharide nanoparticles that can be used in a wide variety of markets ranging from cosmetics to nutraceuticals to applications in human health. The funds will be used to finance a factory to produce PhytoSpherixTM, and to fund at least three years of operations as the company grows.
Norgen Biotek Corp Launches New Portfolio for Next Generation Sequencing, including Library Preparation Kits and Full NGS Service Offering
Norgen Biotek Corp., an innovative Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acid and protein purification and stabilization, today announced the recent launch of their new portfolio of product and service solutions for Next Generation Sequencing (NGS) applications. Norgen has extensive experience with NGS, and has leveraged this expertise to develop a number of new kits and workflows for NGS applications.
Rna Diagnostics Inc. appoints Dr. Matthew P. Goetz to Clinical Advisory Board
Proteocyte Diagnostics: New Study Provides More Straticyte™ Support
CAAP Company: KA Imaging receives funding from FACIT
Ontario Trade Mission to Biotech Showcase 2018
The Biotech Showcase is an investor partnering conference devoted to offering private and public biotechnology and life sciences companies an opportunity to present to and meet with investors and pharma executives.
New Fund: Government of Canada launches Strategic Innovation Fund
Call for Applications: Health IT Canadian Technology Accelerator Fall 2017
CAAP Company: CMAX Technologies Joint Venture Partner BlueOcean NutraSciences Inc. Announces World’s first Omega-3 Oils in XR Tablet Form
BlueOceanNutraSciences Inc. (TSXV:BOC) announced that it has received a Natural Products Number (NPN) from Health Canada for its extended release Omega-3 astaxanthin shrimp oil tablets (“XR tablets”), the World’s first Omega-3 oils in XR tablet form.
The Company’s shrimp oil XR tablets were developed by its joint venture partner, CMAX Technologies Inc. (“CMAX”).